Issue 12, 2026, Issue in Progress

Nanoencapsulation of Rhodiola rosea extract into 2-hydroxypropyl-β-cyclodextrin: enhanced antibacterial and anticancer activities

Abstract

The methanolic extract of Rhodiola rosea (RRME) exhibits multifaceted biological functions, notably antioxidant, anti-inflammatory, and neuroprotective potential. These properties are primarily associated with its rich therapeutic phytochemicals such as salidroside, rosavin, and tyrosol, which contribute to its potential therapeutic applications in managing stress-related disorders and neurodegenerative conditions. In this study, RRME was extracted using the Soxhlet method and subsequently encapsulated in (2-hydroxypropyl)-beta-cyclodextrin (HPβCD) using the freeze-drying technique, forming inclusion complexes (RRME-ICs). RRME-ICs were spherical morphologies with a size range of 87.36 to 166.5 nm. The ICs had a polydispersity index of 0.283 ± 0.01 and %EE of 78.88 ± 1.55%. FT-IR, 1H NMR, 2D NMR NOESY, and TGA demonstrated the effective incorporation of RRME into HPβCD and enhanced integrity with a high thermal stability up to 350 °C. RRME-ICs demonstrated strong antibacterial effects compared to the extract. The MIC90 of RRME exceeded 20 mg mL−1 against Escherichia coli, Pseudomonas putida, and Staphylococcus aureus, indicating limited antibacterial potency. Release kinetics analysis confirmed that the Korsmeyer–Peppas model provided the best fit for RRME-ICs across both pH conditions. RRME-ICs demonstrated remarkable antibacterial activity, with IC90 of 2.38, 3.95, and 1.92 mg mL−1 against E. coli, P. putida, and S. aureus, respectively. Additionally, RRME-ICs preserved antioxidant activity in the DPPH scavenging assay, demonstrating 92.6% scavenging efficiency with an IC50 value of 0.0657 mg mL−1. RRME-ICs also exhibited notable anticancer potential against melanoma (A375) cells with IC50 of 48.14 µg mL−1, compared to RRME (IC50 = 131.24 µg mL−1). In conclusion, encapsulation through HPβCD inclusion complex formation improved its antibacterial and anticancer activities while preserving its antioxidant activity.

Graphical abstract: Nanoencapsulation of Rhodiola rosea extract into 2-hydroxypropyl-β-cyclodextrin: enhanced antibacterial and anticancer activities

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
17 Oct 2025
Accepted
14 Feb 2026
First published
26 Feb 2026
This article is Open Access
Creative Commons BY license

RSC Adv., 2026,16, 11271-11283

Nanoencapsulation of Rhodiola rosea extract into 2-hydroxypropyl-β-cyclodextrin: enhanced antibacterial and anticancer activities

S. Khorshed, A. M. Abdeldayem, W. Fritsche and H. M. E. Azzazy, RSC Adv., 2026, 16, 11271 DOI: 10.1039/D5RA07949G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements